18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson’s disease.

18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson’s disease.
Related Articles18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson's disease. Eur J Med Chem. 2021 Feb 04;214:113245 Authors: Chen X, Zhang Q, Zhang Y, Fang J, Jiang D, Mou Z, Liu H, Su R, Wang C, He F, Chen X, Xie F, Pan X, Li Z Abstract 18F-Labelled pyrrolopyrimidines were synthesized and evaluated as positron emission ... read more
Source: PubMedPublished on 2021-02-16